Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus-associated glomerulonephritis

C Stehman-Breen1, R Willson, C E Alpers

  • 1Division of Nephrology, University of Washington Medical Center, Seattle, USA.

Current Opinion in Nephrology and Hypertension
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Hepatitis C virus heteroduplex tracking assay : application to genotype determination, quasispecies analysis, and molecular evolution studies.

Methods in molecular medicine·2011
Same author

Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents.

Current medical research and opinion·2009
Same author

Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.

Journal of viral hepatitis·2008
Same author

Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
Same author

A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy.

Clinical nephrology·2006

Hepatitis C virus (HCV) infection can cause kidney disease like glomerulonephritis. While interferon-alpha shows promise, optimal treatment for HCV-related kidney issues requires further research.

Area of Science:

  • Nephrology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease.
  • HCV is linked to extrahepatic manifestations, including cryoglobulinemia and glomerulonephritis.
  • Epidemiological data indicate HCV as a significant risk factor for cryoglobulinemic and type I membranoproliferative glomerulonephritis (MPGN).

Purpose of the Study:

  • To review the association between Hepatitis C virus (HCV) infection and glomerulonephritis.
  • To discuss the clinical presentation, pathogenesis, and treatment of HCV-associated MPGN.

Main Methods:

  • Review of epidemiological evidence and clinical data.
  • Analysis of laboratory findings in patients with HCV-associated MPGN.
  • Evaluation of treatment outcomes with interferon-alpha.

Related Experiment Videos

Main Results:

  • HCV-associated MPGN often presents with hypocomplementemia, rheumatoid factors, and cryoglobulinemia.
  • The proposed pathogenesis involves glomerular deposition of circulating HCV and anti-HCV antibodies.
  • Interferon-alpha therapy can improve proteinuria, reduce viral load, and stabilize renal function, but relapses are common.

Conclusions:

  • HCV is a significant risk factor for MPGN.
  • Interferon-alpha offers temporary benefits, but long-term treatment strategies for HCV-related kidney disease are still under investigation.
  • Optimal therapeutic approaches may involve modified interferon-alpha regimens or combination antiviral therapies.